In patients with nontraumatic osteonecrosis of the femoral head, serum sclerostin levels were lower than controls, and the decrease was related to the stage of osteonecrosis, meaning the higher the stage, the lower the levels of serum sclerostin that were measured [58]. This evidence concerns the gene SOST and osteonecrosis.